Cefixim CAS:79350-37-1
Cefixim is frequently used to treat infections such as otitis media, sinusitis, pharyngitis, tonsillitis, bronchitis, urinary tract infections, and gonorrhea. Its oral formulation provides flexibility and ease of administration for patients requiring outpatient therapy for bacterial diseases. Healthcare providers determine the appropriate dosage, frequency, and duration of cefixim therapy based on the specific infection, the identified pathogen, and individual patient characteristics. Patients are advised to take cefixim as directed and complete the full course of antibiotics to ensure effective eradication of the infection. Regular monitoring for potential side effects, allergic reactions, and treatment efficacy is important during cefixim therapy. Adherence to prescribed dosing schedules and completion of the full antibiotic course are crucial to prevent relapse and minimize the development of antibiotic resistance. By following recommended usage guidelines and best practices in prescribing cefixim, healthcare professionals aim to effectively manage bacterial infections while reducing the risk of resistant strains emerging. Collaboration between healthcare providers and patients, along with vigilant monitoring throughout treatment, supports safe and effective use of cefixim to achieve positive outcomes in managing bacterial infections.
Composition | C16H15N5O7S2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 79350-37-1 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |